[go: up one dir, main page]

CL2019001212A1 - Injertos de tejido de amnios y métodos de preparación y uso de los mismos. - Google Patents

Injertos de tejido de amnios y métodos de preparación y uso de los mismos.

Info

Publication number
CL2019001212A1
CL2019001212A1 CL2019001212A CL2019001212A CL2019001212A1 CL 2019001212 A1 CL2019001212 A1 CL 2019001212A1 CL 2019001212 A CL2019001212 A CL 2019001212A CL 2019001212 A CL2019001212 A CL 2019001212A CL 2019001212 A1 CL2019001212 A1 CL 2019001212A1
Authority
CL
Chile
Prior art keywords
preparing
methods
tissue grafts
amnion tissue
graftes
Prior art date
Application number
CL2019001212A
Other languages
English (en)
Inventor
Curt Deister
Original Assignee
Axogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axogen Corp filed Critical Axogen Corp
Publication of CL2019001212A1 publication Critical patent/CL2019001212A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/22—Materials or treatment for tissue regeneration for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pens And Brushes (AREA)

Abstract

LA INVENCIÓN PROPORCIONA UN MÉTODO PARA PREPARAR INJERTOS DE TEJIDO DE AMNIOS, ASÍ COMO LOS INJERTOS EN SÍ MISMOS. EN MODALIDADES ESPECÍFICAS, EL INJERTO DE TEJIDO COMPRENDE UNA SOLA CAPA DE AMNIOS SECOS DE UN CORDÓN UMBILICAL.
CL2019001212A 2016-11-02 2019-05-02 Injertos de tejido de amnios y métodos de preparación y uso de los mismos. CL2019001212A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662416528P 2016-11-02 2016-11-02

Publications (1)

Publication Number Publication Date
CL2019001212A1 true CL2019001212A1 (es) 2019-09-23

Family

ID=62076479

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019001212A CL2019001212A1 (es) 2016-11-02 2019-05-02 Injertos de tejido de amnios y métodos de preparación y uso de los mismos.

Country Status (12)

Country Link
US (2) US11577001B2 (es)
EP (2) EP3534981B1 (es)
JP (2) JP7171588B2 (es)
KR (3) KR20230031381A (es)
AU (2) AU2017353847B2 (es)
CA (1) CA3042751A1 (es)
CL (1) CL2019001212A1 (es)
IL (2) IL301474B2 (es)
MX (3) MX2019005172A (es)
NZ (1) NZ753034A (es)
SG (1) SG11201903899VA (es)
WO (1) WO2018085527A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ753034A (en) * 2016-11-02 2023-04-28 Axogen Corp Amnion tissue grafts and methods of preparing and using same
WO2023021525A1 (en) * 2021-08-16 2023-02-23 Lifecell International Pvt. Ltd A human amnion-chorion based wound dressing material and method thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801299A (en) * 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
DE69416124T2 (de) 1993-06-18 1999-08-05 Polymer Technology Corp Zusammensetzung zur reinigung und befeuchtung von kontaktlinsen
US20030187515A1 (en) 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
US8100872B2 (en) * 2002-10-23 2012-01-24 Tyco Healthcare Group Lp Medical dressing containing antimicrobial agent
WO2005001080A2 (en) * 2003-06-27 2005-01-06 Ethicon, Incorporated Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
ES2537030T3 (es) * 2004-03-17 2015-06-01 Revivicor, Inc. Productos de tejidos derivados de animales que carecen de cualquier expresión de alfa-1,3-galactosiltransferasa funcional
EP1919500A2 (en) * 2005-07-13 2008-05-14 Anthrogenesis Corporation Treatment of leg ulcers using placenta derived collagen biofabric
EP1944045B1 (en) * 2005-07-25 2013-09-18 Foundation for Biomedical Research and Innovation Sheet-like composition
US8932641B2 (en) 2005-08-26 2015-01-13 Amnos Co., Ltd. Dried amnion and method for drying treatment of amnion
WO2007029676A1 (ja) * 2005-09-07 2007-03-15 Arblast Co., Ltd. 生体組織シート及びその作製方法
US8187639B2 (en) * 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
CN2905071Y (zh) * 2006-04-07 2007-05-30 苗九昌 生物羊膜
JP2008022715A (ja) 2006-07-18 2008-02-07 Nipro Corp 細胞シート培養方法及び細胞培養容器
WO2008021391A1 (en) * 2006-08-15 2008-02-21 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
US8372437B2 (en) * 2006-08-17 2013-02-12 Mimedx Group, Inc. Placental tissue grafts
CA2736663C (en) * 2007-09-07 2018-01-02 Surgical Biologics, Llc. Placental tissue grafts and improved methods of preparing and using the same
KR100947553B1 (ko) * 2008-02-14 2010-03-12 주식회사 바이오랜드 생체조직 이식재 및 그의 제조 방법
US9480549B2 (en) 2008-04-25 2016-11-01 Allosource Multi-layer tissue patches
WO2011031489A2 (en) * 2009-08-25 2011-03-17 Tissuetech, Inc. Umbilical cord amniotic membrane products
WO2012003377A2 (en) * 2010-06-30 2012-01-05 Tissuetech, Inc. Methods of preparing chorion tissue and products derived therefrom
KR20210104178A (ko) * 2011-02-14 2021-08-24 미메딕스 그룹 인크. 바르톤 젤리로 이루어진 라미네이트된 조직 이식편 및 그것의 제조 및 사용 방법
CN103874762A (zh) * 2011-08-26 2014-06-18 组织技术公司 胎儿支持组织的灭菌方法
ES2695579T3 (es) * 2011-12-30 2019-01-09 Vivex Biomedical Inc Matriz de regeneración de tejido
CN105521523A (zh) 2015-11-20 2016-04-27 金艺鹏 一种犬羊膜的制备及保存方法
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
NZ753034A (en) * 2016-11-02 2023-04-28 Axogen Corp Amnion tissue grafts and methods of preparing and using same

Also Published As

Publication number Publication date
NZ753034A (en) 2023-04-28
JP7482958B2 (ja) 2024-05-14
IL301474B2 (en) 2025-09-01
JP7171588B2 (ja) 2022-11-15
AU2017353847B2 (en) 2022-04-21
KR20230031381A (ko) 2023-03-07
JP2019536596A (ja) 2019-12-19
US11577001B2 (en) 2023-02-14
IL301474A (en) 2023-05-01
AU2017353847A1 (en) 2019-05-23
IL266381B1 (en) 2023-12-01
EP3534981A2 (en) 2019-09-11
US20190282732A1 (en) 2019-09-19
NZ793788A (en) 2024-10-25
MX2019005172A (es) 2019-09-26
US20230191001A1 (en) 2023-06-22
CA3042751A1 (en) 2018-05-11
WO2018085527A3 (en) 2018-06-28
JP2022184888A (ja) 2022-12-13
US12263276B2 (en) 2025-04-01
EP3534981B1 (en) 2025-12-24
AU2022206749A1 (en) 2022-08-18
IL301474B1 (en) 2025-05-01
EP4663211A2 (en) 2025-12-17
IL266381B2 (en) 2024-04-01
KR102514753B1 (ko) 2023-03-27
SG11201903899VA (en) 2019-05-30
MX2023007919A (es) 2023-07-13
MX2024008143A (es) 2024-07-15
AU2022206749B2 (en) 2024-05-30
IL266381A (en) 2019-06-30
EP3534981A4 (en) 2020-06-24
KR20190104991A (ko) 2019-09-11
KR102860731B1 (ko) 2025-09-15
WO2018085527A2 (en) 2018-05-11
KR20240110869A (ko) 2024-07-16

Similar Documents

Publication Publication Date Title
CO2020016619A2 (es) Anticuerpos biespecificos anti-pvrig/anti-tigit y métodos de uso
CY1123823T1 (el) Βελτιωμενες συνθεσεις τ κυτταρων
CY1123290T1 (el) Ενωσεις και μεθοδοι χρησης
CR20160500A (es) Anticuerpos anti-ox40 y métodos de uso
MX2017007049A (es) Anticuerpos anti-cd79b y métodos de uso.
CL2018003366A1 (es) Anticuerpos anti -cd40 y sus usos
MX2017005920A (es) Anticuerpos anti-tim3 y metodos de uso.
MX2016013512A (es) Sistemas y metodos para el uso simultaneo del espectro dentro del espectro usado activamente.
MX2016010433A (es) Anticuerpos anti-jagged1 y metodos de uso.
CL2017000590A1 (es) Anticuerpos anti-cll-1 e inmunoconjugados
ECSP17063327A (es) Receptores de antígeno quiméricos anti–dll3 y métodos de uso
MX2021007768A (es) Anticuerpos anti-ctla4 y metodos de uso de los mismos.
CO2017001573A2 (es) Receptor quimérico de antígeno anti-cd123
CR20190271A (es) Anticuerpos antitau y métodos de uso
CO2017005784A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
MX2020001406A (es) Mavacamten para su uso en el tratamiento de la cardiomiopatia hipertrofica.
CR20180013A (es) Anticuerpos anti-tau y métodos de uso.
MX2017005553A (es) Terapia de combinacion para cancer.
AR095233A1 (es) Métodos y composiciones para el control de malezas
MX2019011789A (es) 2-(2,4-difluorofenil)-1,1-difluoro-1-(5-sustituido-piridin-2-il)- 3-(1h-tetrazol-1-il)propan-2-oles y procesos para su preparacion.
MX2020003515A (es) Laminados elasticos con elasticos curvos y metodos para la fabricacion.
IL281504A (en) Methods and kits for preparing pathogen-inactivated whole blood
MX2020008801A (es) Células presentadoras de antígeno universal y usos de las mismas.
MX2019012352A (es) Composiciones, sistemas, kits y metodos para ablacion neural.
MX2020003314A (es) Expansion y uso de fracciones de celulas nk ampliadas.